Year |
Citation |
Score |
2017 |
Trucco M, Barredo J, Goldberg J, Hale G, Gill J, Setty B, Smith T, Lee J, Reed D. Abstract CT145: A phase I window, dose escalating and safety trial of Metformin in combination with induction chemotherapy (VPLD)in relapsed/refractory acute lymphoblastic leukemia: NCT01324180 Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Ct145 |
0.303 |
|
2015 |
Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty JW, Williams CR, Schreiber F, Parnes HL, Sebti S, Kazi A, Kang L, Quinn GP, ... Smith T, et al. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Cancer Prevention Research (Philadelphia, Pa.). PMID 25873370 DOI: 10.1158/1940-6207.Capr-14-0324 |
0.356 |
|
2015 |
Kumar NB, Pow-Sang J, Egan K, Spiess PE, Dickinson SI, Salup R, Helal M, McLarty J, Williams CR, Schreiber FJ, Parnes H, Sebti S, Kazi A, Kang L, Quinn GP, ... Smith T, et al. Effect of green tea catechins in prostate cancer chemoprevention. Journal of Clinical Oncology. 33: 1572-1572. DOI: 10.1200/Jco.2015.33.15_Suppl.1572 |
0.352 |
|
2015 |
Kumar NB, Pow-Sang J, Egan KM, Spiess PA, Dickinson S, Salup R, Helal M, McLarty J, Williams CR, Schreiber F, Sebti S, Kazi A, Kang L, Quinn G, Smith T, et al. Abstract PR06: Effect of polyphenon E on progression to prostate cancer after diagnosis of high grade prostatic intraepithelial neoplasia Cancer Prevention Research. 8. DOI: 10.1158/1940-6215.Prev-14-Pr06 |
0.382 |
|
2013 |
Taing MU, Smith T, Singla N, Johnson RE, Chang CH. The relationship between learning goal orientation, goal setting, and performance: A longitudinal study Journal of Applied Social Psychology. 43: 1668-1675. DOI: 10.1111/Jasp.12119 |
0.395 |
|
2012 |
Kumar N, Crocker T, Smith T, Connors S, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, et al. Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures. Journal of Clinical Trials. 2. PMID 24533253 DOI: 10.4172/Jctr.1000105 |
0.384 |
|
2012 |
Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Connors S, Chornukur G, Dickinson SI, Bai W, Williams CR, Salup R, Fu W. Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures. Journal of Cancer Science & Therapy. 2011. PMID 22422102 DOI: 10.4172/1948-5956.S3-007 |
0.375 |
|
2012 |
Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, et al. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemporary Clinical Trials. 33: 279-85. PMID 22101219 DOI: 10.1016/J.Cct.2011.11.004 |
0.356 |
|
Show low-probability matches. |